Akt Antibody Market – Diagnostic Biomarker Discovery Supporting Clinical Translation
Market Overview
The Akt antibody market is extending beyond research applications into diagnostic biomarker discovery as soon seek to identify patients most likely to benefit from Akt-targeted therapies. Pathology laboratories are exploring phospho-Akt immunohistochemistry as a predictive biomarker for PI3K-Akt pathway inhibitors, analogous to HER2 testing for trastuzumab eligibility. Antibody...
